Two-year interim results from a 5-year study evalu... [Australas J Dermatol. 2006] - Pu... - 0 views
-
avivajazz jazzaviva on 24 Jul 11The proportion of subjects who were clinically clear at the 2-year follow-up visit was estimated to be 82.0%. Imiquimod was tolerated when applied daily, with erythema reported for all subjects participating in the study. The recurrence rate observed suggests that once daily dosing and 5x/week dosing yield similar clearance rates, but daily dosing increases local skin reactions.